<DOC>
	<DOC>NCT01332799</DOC>
	<brief_summary>Cardiovascular disease is the leading cause of mortality in kidney transplantation. The enzyme xanthine oxidase may play an important role in the cardiovascular disease of kidney transplant recipients. Inhibiting this enzyme with allopurinol may improve vascular health and protects against cardiovascular complications.</brief_summary>
	<brief_title>Xanthine Oxidase Inhibition in Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Allopurinol</mesh_term>
	<criteria>age 18 years or older both genders recipients of living donor or deceaseddonor kidney transplant with stable renal function history of gout allergy to allopurinol use of azathioprine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cardiovascular disease</keyword>
	<keyword>kidney transplantation</keyword>
</DOC>